Media Summary: Gene therapies hold great potential in neurology, but the limitations of current viral vectors are hampering progress. Todd Carter ... Subscribe to our channel and visit for breaking life science news, exclusive interviews, and more. by Andrew Steinsapir, MBA, Apertura Gene Therapy and Deerfield Management.
Novel Brain Penetrant Capsids For - Detailed Analysis & Overview
Gene therapies hold great potential in neurology, but the limitations of current viral vectors are hampering progress. Todd Carter ... Subscribe to our channel and visit for breaking life science news, exclusive interviews, and more. by Andrew Steinsapir, MBA, Apertura Gene Therapy and Deerfield Management. This activity is supported by an educational grant from BioMarin Pharmaceutical, Inc., CSL Behring, Pfizer, and Spark ... Dr. Hanlon discussed his work on the development and characterization of AAV variants with enhanced CNS transduction ... In this webinar, hear expert testimony about the practical applications of HiFi sequencing in creating
Alan Beggs, PhD Director of the Manton Center for Orphan Disease Research Sir Edwin and Lady Manton Professor of Pediatrics, ... Presented By: David Shaffer, PhD Speaker Biography: David Schaffer's research program employs molecular and cellular ... Gene therapy holds immense promise, but how do you ensure the therapeutic payload gets to the exact right target? Delivering ... New AAVs for Central Nervous System Targeting - David Schaffer Scientific Symposium from the American Society of Gene & Cell ... Gene therapy has emerged as one research area with the potential to provide long sought-after answers for ALS. To discuss the ... Alessio Di Fonzo, MD, PhD, IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy, discusses the prospect of gene ...
Wyss researchers have created a high-throughput platform to generate an Adeno-associated virus 2 (AAV2) library containing ...
